Resource centre

Providing expertise to support pre-formulation development. Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid-state characterization.

With over 30 years of experience in small molecule drug development, Quotient Sciences possesses the expertise to overcome the challenges that arise with HPAPIs.

Our Translational Pharmaceutics approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.

With more than 30 years’ experience, Quotient is a leader in the development, manufacture and assessment of inhalation products, helping clients to accelerate molecules from first-in-human through to proof-of-concept.

We use a broad range of formulation approaches to address complex solubility and bioavailability challenges, ensuring technology selection is driven by molecule need.

Understanding that early phase clinical testing is a pivotal milestone in the development of your drug product, Quotient Sciences offers clinical trial manufacturing, testing and certification services designed to meet your individual requirements.

We offer commercial manufacturing of small molecule products including niche therapies like oncology, orphan and pediatric indications.